Function

Valticetine hydrobromide is considered to be a novel multi-model antidepressant drug. In vitro studies have shown that it can antagonize 5-HT3, 5-HT7, and 5-HT1D receptors, activate 5-HT1A receptors, and partially activate 5- HT1B receptors, and inhibit 5-HT transport.

Vortioxetine is another antidepressant drug that was developed to replace the patent expired drug citalopram.

Application

Valticetine hydrobromide is considered to be a novel multi-model antidepressant drug. In vitro studies have shown that it can antagonize 5-HT3, 5-HT7 and 5-HT1D receptors, activate 5-HT1A receptors, and partially activate 5- HT1B receptors and inhibit 5-HT transport.
 

For the treatment of mild to moderate or severe depression Neurogenic and Reactive Depression Physiotherapy, especially gastrointestinal distress Depression Anxiety Depression in patients with alcohol dependence during withdrawal.